374 related articles for article (PubMed ID: 16123425)
1. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
[TBL] [Abstract][Full Text] [Related]
4. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response.
Giavina-Bianchi P; Kalil J; Rizzo LV
Acta Ophthalmol; 2008 Sep; 86(6):670-5. PubMed ID: 18752518
[TBL] [Abstract][Full Text] [Related]
5. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
6. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Tsuru E; Ueno H
Immunol Lett; 2006 Nov; 107(2):119-24. PubMed ID: 16987553
[TBL] [Abstract][Full Text] [Related]
8. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
9. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
10. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
[TBL] [Abstract][Full Text] [Related]
11. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
12. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.
Leonardi A; DeFranchis G; Zancanaro F; Crivellari G; De Paoli M; Plebani M; Secchi AG
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3036-40. PubMed ID: 10549670
[TBL] [Abstract][Full Text] [Related]
13. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
Fukushima A; Sumi T; Fukuda K; Yamaguchi T; Kumagai N; Nishida T; Ueno H
Immunol Lett; 2006 Sep; 107(1):32-40. PubMed ID: 16930723
[TBL] [Abstract][Full Text] [Related]
14. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
[TBL] [Abstract][Full Text] [Related]
15. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
[TBL] [Abstract][Full Text] [Related]
16. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
[TBL] [Abstract][Full Text] [Related]
17. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
18. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
Sari A; Dinc E; Yilmaz BC; Adiguzel U; Oztuna S; Tasdelen B
Ophthalmic Res; 2010; 44(2):119-24. PubMed ID: 20523103
[TBL] [Abstract][Full Text] [Related]
19. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
Ishida W; Tsuru E; Tominaga A; Miyazaki JI; Higuchi T; Sakamoto S; Fukushima A
Br J Ophthalmol; 2009 Dec; 93(12):1680-5. PubMed ID: 19692377
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
